Home › NDC Lookup › RxCUI directory › RxCUI 1370976

Ospemifene 60 MG Oral Tablet — RxCUI 1370976

RxNorm drug concept · Semantic clinical drug
RxCUI 1370976 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1370976
Official nameOspemifene 60 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped1
Package NDCs mapped4
Reported Medicaid activity (SDUD)652 prescriptions · 10 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Ospemifene: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It treats moderate to severe painful sex and moderate to severe vaginal dryness caused by menopause. Both are symptoms of vulvar and vaginal atrophy. It is not meant for anything e...
  • Take one tablet by mouth once a day with food. Food helps your body absorb it. Your prescriber should use it for the shortest time that works for you and check in periodically on w...
  • The most common ones are hot flushes, vaginal discharge, muscle spasms, headache, sweating and night sweats. Some women have vaginal bleeding. Tell your doctor about any bleeding t...
  • Signs of a stroke or a blood clot in the leg or lung need emergency care. Stop the medicine if you suspect either. Also seek help for hives, rash, itching or swelling that could be...
📖 Read our full Ospemifene guide →

🕸️ Concept Web — How Ospemifene 60 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Ospemifene 60 MG Oral Tablet RxCUI 1370976

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Ospemifene 1370971
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Osphena 1370977
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Ospemifene Oral Tablet 1370975
    • Ospemifene Oral Product 1370973
    • Ospemifene Pill 1370974
    • Ospemifene Oral Tablet [Osphena] 1370979
    • Osphena Oral Product 1370980
    • Osphena Pill 1370981
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Ospemifene 60 MG SCDC · 1370972
  • Ospemifene Oral Tablet SCDF · 1370975
  • Ospemifene Oral Product SCDG · 1370973
  • Ospemifene Pill SCDG · 1370974

Brand-Name Concepts

  • Ospemifene 60 MG Oral Tablet [Osphena] SBD · 1370982
  • Ospemifene 60 MG [Osphena] SBDC · 1370978
  • Ospemifene Oral Tablet [Osphena] SBDF · 1370979
  • Osphena Oral Product SBDG · 1370980
  • Osphena Pill SBDG · 1370981
  • Osphena BN · 1370977

📦 FDA Products & Package NDCs

1 product · 4 package NDCs
4 package NDCs map to RxCUI 1370976 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
55494-0580-18 1 BLISTER PACK in 1 PACKAGE (55494-580-18) / 15 TABLET, FIL... Osphena Duchesnay USA, Inc. 2023-04-01
55494-0580-30 30 TABLET, FILM COATED in 1 BOTTLE (55494-580-30) Osphena Duchesnay USA, Inc. 2023-08-01
55494-0580-55 1 BLISTER PACK in 1 PACKAGE (55494-580-55) / 5 TABLET, FILM... Osphena Duchesnay USA, Inc. 2023-04-01
55494-0580-90 90 TABLET, FILM COATED in 1 BOTTLE (55494-580-90) Osphena Duchesnay USA, Inc. 2023-04-01
Observed labelers: Duchesnay USA, Inc. (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$8.1788
Range $8.1788–$8.1788 · middle 50% $8.1788–$8.1788 · 2 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.